Are inhibin alpha-subunit and the inhibin coreceptor betaglycan downregulated in endometrial carcinoma?
The lower inhibin alpha and betaglycan expression in endometrial adenocarcinoma suggests that the inhibin action may be disrupted. However, the expression of betaglycan in the endothelia of the tumour vasculature suggests that a selective vascular response to inhibin may be possible in these tumours.
Preoperative systemic chemotherapy didn't increase the risk of liver resection.